TY  - JOUR
AU  - Lopez-Montesinos, Inmaculada
AU  - Gomez-Zorrilla, Silvia
AU  - Palacios-Baena, Zaira Raquel
AU  - Prim, Nuria
AU  - Echeverria-Esnal, Daniel
AU  - Gracia, Maria Pilar
AU  - Montero, Maria Milagro
AU  - Duran-Jorda, Xavier
AU  - Sendra, Elena
AU  - Sorli, Luisa
AU  - Guerri-Fernandez, Roberto
AU  - Padilla, Eduardo
AU  - Grau, Santiago
AU  - Horcajada, Juan Pablo
PY  - 2021
DO  - 10.1007/s40121-021-00570-z
SN  - 2193-8229
UR  - http://hdl.handle.net/10668/21530
T2  - Infectious diseases and therapy
AB  - Introduction Extensively drug-resistant (XDR) Pseudomonas aeruginosa (PA) infections are difficult to treat. We aimed to compare aminoglycosides or polymyxin monotherapy versus other antibiotic regimens (carbapenems, aztreonam, ceftazidime, cefepime,...
LA  - en
PB  - Springer london ltd
KW  - Extensively drug-resistant Pseudomonas aeruginosa
KW  - Urinary tract infections
KW  - Amikacin
KW  - Colistin
KW  - Antimicrobial stewardship
KW  - Sepsis
KW  - Mortality
KW  - Anti-Bacterial Agents
KW  - Ceftazidime
KW  - Amikacin
KW  - ceftolozane
KW  - Aztreonam
KW  - Aminoglycosides
KW  - Pseudomonas aeruginosa
TI  - Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study
TY  - research article
VL  - 11
ER  -